Immatics NV (IMTX)
8.70
-0.23
(-2.58%)
USD |
NASDAQ |
Aug 24, 16:00
8.70
0.00 (0.00%)
After-Hours: 20:00
Immatics Debt to Equity Ratio : 0.0365 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0365 |
| March 31, 2026 | 0.0331 |
| December 31, 2025 | 0.0323 |
| September 30, 2025 | 0.0393 |
| June 30, 2025 | 0.0368 |
| March 31, 2025 | 0.0345 |
| December 31, 2024 | 0.0312 |
| September 30, 2024 | 0.0805 |
| June 30, 2024 | 0.0928 |
| March 31, 2024 | 0.0813 |
| December 31, 2023 | 0.1528 |
| September 30, 2023 | 0.1634 |
| June 30, 2023 | 0.1808 |
| March 31, 2023 | 0.1224 |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 0.2443 |
| March 31, 2022 | 0.1775 |
| December 31, 2021 | 1.567 |
| September 30, 2021 | 0.9458 |
| June 30, 2021 | 0.0923 |
| March 31, 2021 | 0.0678 |
| December 31, 2020 | 0.2638 |
| September 30, 2020 | 0.0561 |
| June 30, 2020 | -0.1091 |
| March 31, 2020 | -0.0757 |
| December 31, 2019 | -0.0773 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| MediGene AG | -- |
| InflaRx NV | 0.0057 |
| BioNTech SE | 0.0178 |
| Moderna, Inc. | 0.1904 |
| Intellia Therapeutics, Inc. | 0.1009 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 555.34M |
| Total Liabilities (Quarterly) | 98.45M |
| Shareholders Equity (Quarterly) | 456.89M |
| Current Ratio | 7.536 |
| Net Debt Paydown Yield | 0.05% |